Opus Genetics has completed a Type B Regenerative Medicine Advanced Therapy (RMAT) meeting with the US Food and Drug ...

Fulgent Genetics, Inc. (FLGT) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of a loss of $0.24 per share. This compares to earnings of $0.31 per share a ...

Large-scale analyses connect genetic risk factors in lupus with ACR-82 clinical manifestations, suggesting genetic risk ...

Prime Medicine, Inc. (PRME) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to a loss of $0.44 per share a year ago. These ...

HLA class I alleles, one known and one newly identified, are linked to allopurinol-induced severe cutaneous adverse reactions ...

Dr. McGuire received her B.A. from the University of Pennsylvania, summa cum laude, her J.D. from the University of Houston ...

A newly identified disorder, MINA syndrome, results from a mutation in the NAMPT protein that deprives motor neurons of ...

Now, a growing body of scientific evidence shows hundreds of genes act differently in the brains of biologically male or ...

With more than 250 peer-reviewed papers published in several high-impact journals, Katalin Susztak, MD, PhD, has opened the ...

Over the the next five years, up to 100,000 people in Ontario will be screened for genetic conditions that increase their ...

Q2 2026 Earnings Call November 5, 2025 8:00 AM ESTCompany ParticipantsSimona King - Chief Financial OfficerMiguel Martin - ...

The prize, honoring “the most outstanding plant scientists working on both genetics and genomics in the present era,” is named after McClintock, a plant biologist whose work in maize genetics earned ...